Interview with Matt Wadyka on the rise of direct to patient programs and the future of pharma engagement

At Reuters Pharma USA in Philadelphia last month, one theme consistently surfaced across discussions: the growing momentum behind direct to patient (DTP) programs. As more pharma companies explore this approach, the industry is increasingly focused on how to balance patient trust and convenience with broader strategic and commercial priorities.

During the event, Matt Wadyka, Chief Client Strategy Officer at Inizio Medical, spoke with pharmaphorum’s Jonah Comstock about what it truly means to put power back into patients’ hands, and the operational, educational, and engagement shifts required to make that possible.

Their conversation also explored the evolving landscape of medical affairs and science education, and how these areas are becoming more closely connected as organizations rethink how they engage increasingly informed and empowered audiences.

AI also featured prominently in the discussion, particularly its role in enabling more personalized, scalable, and patient centric experiences across the healthcare journey.

The interview provides a strong distillation of several of the key conversations and emerging priorities that shaped this year’s event.

Watch the video to hear Matt’s perspective and read the full insight on pharmaphorum here.